Voxel S.A.

Warsaw Stock Exchange VOX.WA

Voxel S.A. EBITDA for the year ending December 31, 2023: USD 38.42 M

Voxel S.A. EBITDA is USD 38.42 M for the year ending December 31, 2023, a 41.53% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.

Voxel S.A. EBITDA for the year ending December 31, 2022 was USD 27.14 M, a -17.82% change year over year.
Voxel S.A. EBITDA for the year ending December 31, 2021 was USD 33.03 M, a 45.56% change year over year.
Voxel S.A. EBITDA for the year ending December 31, 2020 was USD 22.69 M, a 49.96% change year over year.
Voxel S.A. EBITDA for the year ending December 31, 2019 was USD 15.13 M, a 23.55% change year over year.

Key data

Date	EBITDA	Net Income	EPS (Diluted)	Shares (Diluted, Weighted)

Warsaw Stock Exchange: VOX.WA

Voxel S.A.

CEO	Mr. Jaroslaw Furdal
IPO Date	Oct. 11, 2011
Location	Poland
Headquarters	ul. Wielicka 265
Employees	643
Sector	Health Care
Industries Medical Instruments Hospitals & Clinics Telehealth

Description

Voxel S.A. operates a network of diagnostic imaging laboratories. Its diagnostic imaging services include magnetic resonance imaging scans, computed tomography scans, positron emission tomography, and single photon emission computed tomography. The company also provides services in the field of diagnostic imaging, teleradiology, and outsourcing; and information systems for hospitals and diagnostic centers. In addition, it deals with the implementation of projects related to the outfitting of diagnostic laboratories. The company operates through a network of 33 specialized laboratories in 21 cities in Poland. Voxel S.A. was founded in 2005 and is based in Kraków, Poland.

Key trends

Past 5 years